Detalhe da pesquisa
1.
SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer.
Future Oncol
; 16(24): 1801-1813, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32633563
2.
SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer.
Front Oncol
; 11: 638482, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33968735